PT - JOURNAL ARTICLE AU - Filip Ottosson AU - Einar Smith AU - Ulrika Ericson AU - Salvatore Di Somma AU - Paola Antonini AU - Peter M Nilsson AU - CĂ©line Fernandez AU - Olle Melander TI - Metabolome-defined obesity and the risk of future diabetes and mortality AID - 10.1101/2021.11.03.21265744 DP - 2021 Jan 01 TA - medRxiv PG - 2021.11.03.21265744 4099 - http://medrxiv.org/content/early/2021/11/03/2021.11.03.21265744.short 4100 - http://medrxiv.org/content/early/2021/11/03/2021.11.03.21265744.full AB - Background Obesity is a key risk factor for type 2 diabetes, however, up to 20% of patients are normal weight. Our aim was to identify metabolite patterns reproducibly predictive of BMI, and subsequently to test if lean individuals who carry an obese metabolome are at hidden high risk of obesity related diseases, such as diabetes.Methods We measured 109 metabolites in fasted plasma samples of 7663 individuals from two Swedish and one Italian population-based cohort. Ridge regression models were used to predict BMI using the plasma metabolites. Individuals with a predicted BMI either more than 5 kg/m2 higher (overestimated) or lower (underestimated) than their actual BMI were characterized as outliers and further investigated for obesity related risk factors and future risk of diabetes and mortality.Results The plasma metabolome could predict BMI in all cohorts (r2 = 0.48, 0.26 and 0.19). The overestimated group had a BMI similar to individuals correctly predicted as normal weight, similar waist circumference, were not more likely to change weight over time but had a 2 times higher risk of future diabetes and an 80 % increased risk of all-cause mortality. These associations remained after adjustments for obesity-related risk factors and lifestyle parameters.Conclusions We found that lean individuals with an obese metabolome, have an increased risk for diabetes and all-cause mortality compared to lean individuals with a healthy metabolome. Metabolomics may be used to identify hidden high-risk individuals, in order to initiate lifestyle and pharmacological interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Foundation for Strategic Research (IRC LUDC), Swedish Research Council (SFO-EXODIAB), AIR Lund (Artificially Intelligent use of Registers at Lund University) research environment (VR; Grant No. 2019-61406), Lund University Infrastructure Grants for population-based cohorts and metabolomics platforms (STYR 2019/2046), European Research Council AdG 2019-885003, Novo Nordisk Foundation NNF200C0063465, Swedish Research Council grant Dnr 2018-02760, Swedish Heart and Lung Foundation grant Dnr 20180278, Ernhold Lundstrom Research Foundation, Hulda and E Conrad Mossfelts Foundation and the Albert Pahlsson Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The ethics committee of Lund University and The Regional Board of Ethics ASL Napoli Sud approved the study protocolsI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors